Skip to main content

Moderna and Merck show progress toward cancer vaccines

Another exciting development in the treatment of metastatic cancer.  In this study, a combination of a melanoma vaccine and immunotherapy clearly increased long-term survival of patients.  This initial study must be replicated and done in a larger population group to confirm its efficacy and safety. 

Below is the online article:

https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cancer-vaccine-with-mercks-keytruda-delays-return-deadly-skin-cancer-2023-04-16/

You Might Also Enjoy...